Stay updated on Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page.

Latest updates to the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.3.4 in the metadata/footer, replacing Revision: v3.3.3. This is an administrative update that does not alter study content or functionality.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded multiple new study locations across Florida, Illinois, Indiana, Kentucky, Michigan, Missouri, Nebraska, New Jersey, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, and Wisconsin (Revision: v3.3.3).SummaryDifference2%

- Check52 days agoChange DetectedRevision: v3.3.2 has been added to the page. Revision: v3.2.0 has been removed from the page.SummaryDifference0.1%

- Check59 days agoChange DetectedThe funding lapse banner is removed from the page. Study details, eligibility criteria, and location/contact information remain unchanged.SummaryDifference0.4%

- Check74 days agoChange DetectedNo significant updates to core study details were observed; the page content, including title, status, eligibility criteria, interventions, primary outcomes, locations, and enrollment, remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check102 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

Stay in the know with updates to Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page.